|
Invited Speakers:
|
|
Plenary Presentations
Dr. Robert M. Hoffman Ph.D., Anticancer Inc.
Richard Levenson, M.D., CRI, Inc.
Keynote Presentation
Peter Lassota, Ph.D., Novartis Pharmaceuticals Corporation Technology Innovations
Timothy J. Pelura, Ph.D., Kereos, Inc.
Shuming Nie, Ph.D., Georgia Institute of Technology and Emory University School of Medicine
Douglas A. Bakan, Ph.D., Alerion Biomedical, Inc.
Michael Thornton, GE Healthcare
Derek Maclean, Ph.D., KAI Pharmaceuticals Pre-Clinical Imaging
Aladar A. Szalay, Ph.D., University of Wurzburg, and Genelux Corporation
Jan E. Schnitzer, M.D., Sidney Kimmel Cancer Center
Amos Baruch, Ph.D., Celera Genomics
Nikolaus S. Trede, M.D., Ph.D., Harvard Medical School
Harvey R. Herschman, Ph.D., University of California, Los Angeles
Anthony Purchio, Ph.D., CSO, Xenogen, Inc. Clinical Applications
Annick D. Van den Abbeele, M.D., Dana-Farber Cancer Institute and Harvard Medical School
Johannes Czernin, M.D., University of California, Los Angeles
|
|